Blood-brain barrier leakage as a predictive factor for post-stroke epilepsy

Academic hospital Maastricht (azM)0 个研究点目标入组 80 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•Diagnosed with a primary acute stroke (including both cerebral infarction and hemorrhage)
•A SeLECT score = 5 or a CAVE score = 2
•Age of = 18 years

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•Contradictions for a gadolinium-based contrast agent (known allergy or insufficient kidney function determined by an eGFR = 30 mL/min)
•Contradictions for MRI scanning (e.g. metal implants, cardiac pacemaker, claustrophobia, pregnancy)
•Previous history of stroke, epileptic seizures or other cerebral disorders (e.g. neurodegenerative diseases or head/brain tumors)
•Re-infarction during follow-up
•Potential epileptogenic co-morbidities (e.g. alcohol or drugs abuse, cerebral venous thrombosis, history of brain surgery)
•Absence of written informed consent (by a legal representative)

发起方

Academic hospital Maastricht (azM)